Cleared Traditional

THERAPEUTIC STIMULATOR 300(TS-300) & 300P(TS-300P) (K932764) - FDA 510(k) Clearance

Class II Physical Medicine device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1993
Decision
115d
Days
Class 2
Risk

K932764 is an FDA 510(k) clearance for the THERAPEUTIC STIMULATOR 300(TS-300) & 300P(TS-300P). Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.

Submitted by Myo/Kinetic Systems, Inc. (Menomonee Falls, US). The FDA issued a Cleared decision on October 1, 1993 after a review of 115 days - within the typical 510(k) review window.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Myo/Kinetic Systems, Inc. devices

Submission Details

510(k) Number K932764 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 1993
Decision Date October 01, 1993
Days to Decision 115 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 115d · This submission: 115d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IPF Stimulator, Muscle, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IPF Stimulator, Muscle, Powered

All 546
Devices cleared under the same product code (IPF) and FDA review panel - the closest regulatory comparables to K932764.
High Tone Power therapy (HiToP) (Model: HiToP PNP)
K252816 · Mohammadali Nezakati · Jun 2026
StimelMD (SSMD) system
K260142 · Motion Informatics ltd. · May 2026
Compact II
K251083 · Enraf-Nonius, B.V. · Sep 2025
EVE Synergy (EVE-20M)
K241433 · Weero Co., Ltd. · Jun 2025
TrainFES Advance
K241488 · Trainfes · Feb 2025
Quantum Mitohormesis (QMT) (M2101)
K240348 · Quantumtx Pte. , Ltd. · Dec 2024